Previous 10 | Next 10 |
Financials for Second Quarter Fiscal Year 2023 Ended September 30, 2022 will be released on November 14, 2022 NORTHVALE, NJ / ACCESSWIRE / November 8, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic ...
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study NORTHVALE, NJ / ACCESSWIRE / November 2, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today reported po...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips When talking about penny stocks for 10 cents or less, the term “best” may not be a word that first comes to mind. Many penny stocks, almost all of which trade over-the-counter (or OTC) rather than on a major e...
Elite Pharmaceuticals, Inc. (ELTP) Q1 2023 Earnings Conference Call August 16, 2022 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Robert Chen - Chief Financial Officer, Secretary and Treasurer Conference Call Participants...
Elite Pharmaceuticals press release ( OTCQB:ELTP ): Q1 GAAP EPS of $0.00. Revenue of $7.7M (+2.7% Y/Y). For further details see: Elite Pharmaceuticals GAAP EPS of $0.00, revenue of $7.7M
Conference Call Scheduled for Tuesday, August 16 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / August 15, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the first quart...
Financials for First Quarter Fiscal Year 2023 Ended June 30, 2022 will be released on August 15, 2022 NORTHVALE, NJ / ACCESSWIRE / August 11, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products,...
Elite Pharmaceuticals, Inc. (ELTP) Q4 2022 Earnings Conference Call June 30, 2022, 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Robert Chen - Chief Financial Officer Dianne Will - Vice President, Investor Relations Conference Call Parti...
Conference Call Scheduled for Thursday, June 30 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 29, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year e...
NORTHVALE, NJ / ACCESSWIRE / June 29, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it received approval from the US Food and Drug Administration (FDA) for an Abbreviated ...
News, Short Squeeze, Breakout and More Instantly...
Elite Pharmaceuticals Inc. Company Name:
ELTP Stock Symbol:
OTCMKTS Market:
Elite Pharmaceuticals Inc. Website:
Financials for Fiscal Year 2024 Ended March 31, 2024 will be released on July 1, 2024 Northvale, New Jersey--(Newsfile Corp. - June 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced to...